Intuitive Surgical EBITDA Margin 2010-2024 | ISRG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Intuitive Surgical (ISRG) over the last 10 years. The current EBITDA margin for Intuitive Surgical as of September 30, 2024 is .
| Intuitive Surgical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $7.87B | $2.57B | 32.66% |
| 2024-06-30 | $7.57B | $2.45B | 32.33% |
| 2024-03-31 | $7.32B | $2.33B | 31.81% |
| 2023-12-31 | $7.12B | $2.23B | 31.29% |
| 2023-09-30 | $6.85B | $2.17B | 31.70% |
| 2023-06-30 | $6.66B | $2.09B | 31.30% |
| 2023-03-31 | $6.43B | $2.01B | 31.24% |
| 2022-12-31 | $6.22B | $2.02B | 32.47% |
| 2022-09-30 | $6.12B | $2.03B | 33.25% |
| 2022-06-30 | $5.96B | $2.07B | 34.67% |
| 2022-03-31 | $5.91B | $2.17B | 36.73% |
| 2021-12-31 | $5.71B | $2.16B | 37.88% |
| 2021-09-30 | $5.49B | $2.12B | 38.54% |
| 2021-06-30 | $5.16B | $1.93B | 37.36% |
| 2021-03-31 | $4.55B | $1.49B | 32.63% |
| 2020-12-31 | $4.36B | $1.34B | 30.81% |
| 2020-09-30 | $4.31B | $1.31B | 30.36% |
| 2020-06-30 | $4.36B | $1.38B | 31.76% |
| 2020-03-31 | $4.61B | $1.65B | 35.74% |
| 2019-12-31 | $4.48B | $1.59B | 35.50% |
| 2019-09-30 | $4.25B | $1.49B | 35.15% |
| 2019-06-30 | $4.04B | $1.42B | 35.21% |
| 2019-03-31 | $3.85B | $1.32B | 34.22% |
| 2018-12-31 | $3.73B | $1.33B | 35.79% |
| 2018-09-30 | $3.57B | $1.32B | 37.09% |
| 2018-06-30 | $3.46B | $1.28B | 37.08% |
| 2018-03-31 | $3.31B | $1.26B | 38.04% |
| 2017-12-31 | $3.14B | $1.17B | 37.37% |
| 2017-09-30 | $3.01B | $1.09B | 36.29% |
| 2017-06-30 | $2.88B | $1.07B | 37.17% |
| 2017-03-31 | $2.79B | $1.07B | 38.22% |
| 2016-12-31 | $2.71B | $1.05B | 38.90% |
| 2016-09-30 | $2.63B | $1.05B | 40.15% |
| 2016-06-30 | $2.53B | $1.00B | 39.42% |
| 2016-03-31 | $2.45B | $0.92B | 37.42% |
| 2015-12-31 | $2.39B | $0.86B | 35.89% |
| 2015-09-30 | $2.31B | $0.82B | 35.37% |
| 2015-06-30 | $2.27B | $0.77B | 33.66% |
| 2015-03-31 | $2.20B | $0.73B | 33.20% |
| 2014-12-31 | $2.13B | $0.65B | 30.63% |
| 2014-09-30 | $2.10B | $0.65B | 30.81% |
| 2014-06-30 | $2.05B | $0.67B | 32.55% |
| 2014-03-31 | $2.12B | $0.75B | 35.58% |
| 2013-12-31 | $2.27B | $0.96B | 42.25% |
| 2013-09-30 | $2.30B | $0.96B | 41.86% |
| 2013-06-30 | $2.34B | $1.00B | 42.70% |
| 2013-03-31 | $2.30B | $1.00B | 43.53% |
| 2012-12-31 | $2.18B | $0.94B | 42.96% |
| 2012-09-30 | $2.07B | $0.92B | 44.27% |
| 2012-06-30 | $1.98B | $0.88B | 44.33% |
| 2012-03-31 | $1.87B | $0.81B | 43.59% |
| 2011-12-31 | $1.76B | $0.76B | 43.46% |
| 2011-09-30 | $1.65B | $0.73B | 44.06% |
| 2011-06-30 | $1.55B | $0.67B | 43.50% |
| 2011-03-31 | $1.47B | $0.64B | 43.41% |
| 2010-12-31 | $1.41B | $0.61B | 43.38% |
| 2010-09-30 | $1.35B | $0.57B | 42.17% |
| 2010-06-30 | $1.28B | $0.54B | 42.01% |
| 2010-03-31 | $1.19B | $0.50B | 41.74% |
| 2009-12-31 | $1.05B | $0.41B | 39.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $186.606B | $7.124B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.634B | 24.11 |
| Edwards Lifesciences (EW) | United States | $43.604B | 27.69 |
| Alcon (ALC) | Switzerland | $41.521B | 27.78 |
| IQVIA Holdings (IQV) | United States | $34.761B | 19.15 |
| IDEXX Laboratories (IDXX) | United States | $33.493B | 39.44 |
| DexCom (DXCM) | United States | $29.615B | 44.60 |
| Waters (WAT) | United States | $21.413B | 31.66 |
| STERIS (STE) | Ireland | $20.170B | 23.22 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.359B | 0.00 |
| Hologic (HOLX) | United States | $16.058B | 17.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.192B | 13.54 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Globus Medical (GMED) | United States | $11.158B | 28.25 |
| Penumbra (PEN) | United States | $9.346B | 91.55 |
| Masimo (MASI) | United States | $9.102B | 44.04 |
| Teleflex (TFX) | United States | $8.118B | 12.95 |
| Glaukos (GKOS) | United States | $7.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.457B | 25.26 |
| PROCEPT BioRobotics (PRCT) | United States | $4.215B | 0.00 |
| Inari Medical (NARI) | United States | $3.185B | 0.00 |
| Veracyte (VCYT) | United States | $3.028B | 90.86 |
| Nihon Kohden (NHNKY) | Japan | $2.590B | 19.67 |
| LivaNova (LIVN) | United Kingdom | $2.579B | 14.89 |
| Tandem Diabetes Care (TNDM) | United States | $2.185B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.096B | 18.84 |
| TransMedics (TMDX) | United States | $2.031B | 64.39 |
| Integra LifeSciences Holdings (IART) | United States | $1.675B | 8.75 |
| RxSight (RXST) | United States | $1.539B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.255B | 0.00 |
| Artivion (AORT) | United States | $1.173B | 77.69 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Paragon 28 (FNA) | United States | $0.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.760B | 12.92 |
| Mesa Laboratories (MLAB) | United States | $0.714B | 16.83 |
| IRadimed (IRMD) | United States | $0.676B | 36.54 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.657B | 0.00 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.568B | 29.92 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.407B | 22.01 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.357B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.171B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| Nevro (NVRO) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.123B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.118B | 12.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| 908 Devices (MASS) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |